Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 206-114-9 | CAS number: 302-01-2
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Short description of key information on bioaccumulation potential result:
Hydrazine is well absorbed after oral, dermal or inhalational
administration, distributed in the body tissue and metabolized. Beside
the elimination as nitrogen through the lung, urinary excretion of
unchanged hydrazine and its metabolites is the main elimination route
(BUA 1996).
Key value for chemical safety assessment
Additional information
Hydrazine is well absorbed after oral, dermal or inhalational administration. Hydrazine is distributed evenly in the body tissue after administration. Only the kidney reveals higher concentrations than other organs. The concentration of hydrazine in the blood decreases rapidly in a first phase, followed by a slow decline in the second phase. Hydrazine is excreted to about 50 % unchanged in the urine. In addition to nitrogen elimination through the lung, hydrazine metabolites appearing in the urine are mainly acetyl hydrazine, diacetyl hydrazine, 1,4,5,6 tetrahydro-6-oxo-3-pyradazine and pyruvate hydrazone and urea (BUA 1996).
Discussion on bioaccumulation potential result:
Hydrazine is well absorbed after oral , demal or inhalational administration. Hydrazine is distributed evenly in the body tissue after administration. Only the kidney reveals higher concentrations than other organs.The concentration of hydrazine in the blood decreases rapidly in a first phase , followed by a slow decline in the second phase. Hydrazine is excreted to about 50 % unchanged in the urine. In addition to nitrogen eliminated through the lung, hydrazine metabolites appearing in the urine are mainly acetyl hydrazine, diacetylhdrazine, 1,4,5,6 tetrahydro-6-oxo-3-pyradazine and pyruvate hydrazine and urea (BUA 1996).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
